Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INMD Inmode Ltd
- Stocks
- Healthcare
- NASDAQ: INMD
Price (delayed)
$14.67
Market cap
$1.01B
P/E Ratio
6.24
Dividend/share
N/A
EPS
$2.35
Enterprise value
$868.35M
inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and
Highlights
The price to earnings (P/E) is 65% less than the 5-year quarterly average of 17.9 and 27% less than the last 4 quarters average of 8.5
The EPS is up by 8% year-on-year and by 2.6% since the previous quarter
The company's debt fell by 10% YoY but it rose by 5% QoQ
The quick ratio has contracted by 39% YoY and by 17% from the previous quarter
Inmode's equity has decreased by 24% YoY and by 12% QoQ
Key stats
What are the main financial stats of INMD
Market
Valuations
Earnings
Shares outstanding
68.76M
Market cap
$1.01B
Enterprise value
$868.35M
Price to earnings (P/E)
6.24
Price to book (P/B)
1.65
Price to sales (P/S)
2.57
EV/EBIT
6.21
EV/EBITDA
6.18
EV/Sales
2.21
Revenue
$392.41M
Gross profit
$314.06M
Operating income
$110.06M
Net income
$175.78M
EBIT
$139.87M
EBITDA
$140.61M
Free cash flow
$121.95M
Per share
Balance sheet
Liquidity
EPS
$2.35
EPS diluted
$2.33
Free cash flow per share
$1.77
Book value per share
$8.91
Revenue per share
$5.71
TBVPS
$10.25
Total assets
$704.74M
Total liabilities
$85.31M
Debt
$5.59M
Equity
$619.43M
Working capital
$561.98M
Debt to equity
0.01
Current ratio
8.73
Quick ratio
7.54
Net debt/EBITDA
-1
Margins
Efficiency
Dividend
EBITDA margin
35.8%
Gross margin
80%
Net margin
44.8%
Operating margin
28%
Return on assets
22.2%
Return on equity
25%
Return on invested capital
24.1%
Return on capital employed
22.1%
Return on sales
35.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INMD stock price
How has the Inmode stock price performed over time
Intraday
-0.27%
1 week
1.52%
1 month
-1.61%
1 year
-21.3%
YTD
-12.16%
QTD
-17.31%
Financial performance
How have Inmode's revenue and profit performed over time
Revenue
$392.41M
Gross profit
$314.06M
Operating income
$110.06M
Net income
$175.78M
Gross margin
80%
Net margin
44.8%
Inmode's operating income has decreased by 36% YoY and by 2.2% QoQ
Inmode's operating margin has decreased by 25% YoY
The gross profit has declined by 19% year-on-year
INMD's revenue is down by 16% year-on-year
Price vs fundamentals
How does INMD's price correlate with its fundamentals
Growth
What is Inmode's growth rate over time
Valuation
What is Inmode stock price valuation
P/E
6.24
P/B
1.65
P/S
2.57
EV/EBIT
6.21
EV/EBITDA
6.18
EV/Sales
2.21
The price to earnings (P/E) is 65% less than the 5-year quarterly average of 17.9 and 27% less than the last 4 quarters average of 8.5
The EPS is up by 8% year-on-year and by 2.6% since the previous quarter
INMD's P/B is 72% below its 5-year quarterly average of 5.8 and 18% below its last 4 quarters average of 2.0
Inmode's equity has decreased by 24% YoY and by 12% QoQ
INMD's price to sales (P/S) is 65% lower than its 5-year quarterly average of 7.3 and 22% lower than its last 4 quarters average of 3.3
INMD's revenue is down by 16% year-on-year
Efficiency
How efficient is Inmode business performance
The return on invested capital has declined by 25% year-on-year but it rose by 7% since the previous quarter
The ROS is down by 17% year-on-year
INMD's return on equity is up by 3.7% since the previous quarter and by 3.3% year-on-year
Inmode's ROA has increased by 2.8% from the previous quarter
Dividends
What is INMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INMD.
Financial health
How did Inmode financials performed over time
The quick ratio has contracted by 39% YoY and by 17% from the previous quarter
The company's current ratio fell by 35% YoY and by 15% QoQ
The company's debt is 99% lower than its equity
Inmode's equity has decreased by 24% YoY and by 12% QoQ
The company's debt fell by 10% YoY but it rose by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.